11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Bacterial species-identifiable magnetic nanosystems for early sepsis diagnosis and extracorporeal photodynamic blood disinfection

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A bacterial species-identifiable magnetic nanosystem (Fe 3O 4-Ce6-Apt) has been reported for sensitive early sepsis diagnosis and extracorporeal photodynamic blood disinfection.

          Abstract

          Despite the numerous bacteria detection and elimination techniques available nowadays, sensitive diagnosis and treatment of sepsis (caused by the presence of bacteria in the bloodstream), especially at the early stage, remain big challenges. Here we report a nanosystem for early sepsis diagnosis and complete extracorporeal blood disinfection, based on iron oxide magnetic nanoparticles functionalized with chlorin e6 molecules and bacterial species-identifiable aptamers (Fe 3O 4-Ce6-Apt). We demonstrate that the Fe 3O 4-Ce6-Apt nanosystem can achieve simultaneous blood bacterial species identification and enrichment in a single step, and the enriched bacteria can be easily detected with the assistance of fluorescence microscopic determination. Based on this Fe 3O 4-Ce6-Apt nanosystem, successful diagnosis of sepsis caused by a single ( Staphylococcus aureus) or multiple species ( Staphylococcus aureus and Escherichia coli) of bacteria in mice has been realized. Compared to the gold standard blood culture method, this Fe 3O 4-Ce6-Apt nanosystem-based strategy has a comparable detection sensitivity (around 10 colony-forming units) but a significantly shortened diagnosis turnaround time (within 1.5 h), revealing its great potential for early sepsis diagnosis in clinical settings. Moreover, benefitting from the strong photodynamic effect of the Fe 3O 4-Ce6-Apt nanosystem, complete extracorporeal blood disinfection has been achieved. Remarkably, we also demonstrate that the disinfected blood can be reused for mice transfusion application without inducing adverse reactions, indicating the fruitful potential of the Fe 3O 4-Ce6-Apt nanosystem for sepsis treatment. Apart from the sepsis-associated applications, we believe that the Fe 3O 4-Ce6-Apt nanosystem could find wide applications in the fields of health and environmental sciences that require bacteria monitoring and sterilization.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe.

          In this systematic review, we estimated the total number of episodes of bloodstream infection (BSI) and deaths from BSI per year in North America and Europe, using data from population-based settings. Then, we estimated the number of episodes and deaths from nosocomial BSI from population-based studies and nosocomial infection surveillance systems. We estimated 575 000-677 000 episodes of BSI per year in North America (536 000-628 000 in the USA and 40 000-49 000 in Canada) and 79 000-94 000 deaths (72 000-85 000 in the USA and 7000-9000 in Canada), using estimates from three population-based studies. We estimated over 1 200 000 episodes of BSI and 157 000 deaths per year in Europe, using estimates from one population-based study in each of the following countries: Denmark (9100 episodes and 1900 deaths), Finland (8700 episodes and 1100 deaths) and England (96 000 episodes and 12 000-19 000 deaths). There were substantial differences in estimates of nosocomial BSI between population-based and nosocomial infection surveillance data. BSI has a major impact on the morbidity and mortality of the general population, as it ranks among the top seven causes of death in all included countries in North America and Europe. However, it is difficult to obtain precise estimates of nosocomial BSI, owing to the limited number of studies. This review highlights the need for a greater focus on BSI research in order to reduce the overall burden of disease by improving the outcome of patients with BSI. It also emphasizes the role of infection control and prevention methods in reducing the burden of nosocomial BSI. ©2013 The Authors Clinical Microbiology and Infection ©2013 European Society of Clinical Microbiology and Infectious Diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nanomaterials for targeted detection and photothermal killing of bacteria.

            Despite the modern treatment processes, contamination of food, water and medical equipment by pathogenic bacteria is very common in this world. Since the last two decades, one of the most important and complex problems our society has been facing is that several human pathogens became resistant to most of the clinically approved antibiotics. Recent advancement in nanoscience and nanotechnology has expanded our ability to design and construct nanomaterials with targeting, therapeutic, and diagnostic functions. These multifunctional materials have attracted our attention to be used as the promising tool for selective bacteria sensing and therapy without the current drugs. This tutorial review provides the basic concepts and critical properties of the different nanostructures that are useful for the pathogen detection and photothermal applications. In addition, bio-conjugated nanomaterial based strategies have been discussed with the aim to provide readers an overview of exciting opportunities and challenges in this field. This journal is © The Royal Society of Chemistry 2012
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein.

              The antimicrobial defence of Drosophila relies largely on the challenge-induced synthesis of an array of potent antimicrobial peptides by the fat body. The defence against Gram-positive bacteria and natural fungal infections is mediated by the Toll signalling pathway, whereas defence against Gram-negative bacteria is dependent on the Immune deficiency (IMD) pathway. Loss-of-function mutations in either pathway reduce the resistance to corresponding infections. The link between microbial infections and activation of these two pathways has remained elusive. The Toll pathway is activated by Gram-positive bacteria through a circulating Peptidoglycan recognition protein (PGRP-SA). PGRPs appear to be highly conserved from insects to mammals, and the Drosophila genome contains 13 members. Here we report a mutation in a gene coding for a putative transmembrane protein, PGRP-LC, which reduces survival to Gram-negative sepsis but has no effect on the response to Gram-positive bacteria or natural fungal infections. By genetic epistasis, we demonstrate that PGRP-LC acts upstream of the imd gene. The data on PGRP-SA with respect to the response to Gram-positive infections, together with the present report, indicate that the PGRP family has a principal role in sensing microbial infections in Drosophila.
                Bookmark

                Author and article information

                Journal
                NANOHL
                Nanoscale
                Nanoscale
                Royal Society of Chemistry (RSC)
                2040-3364
                2040-3372
                2018
                2018
                : 10
                : 1
                : 132-141
                Affiliations
                [1 ]School of Pharmaceutical Engineering and Life Sciences
                [2 ]Changzhou University
                [3 ]Changzhou 213164
                [4 ]China
                [5 ]School of Radiation Medicine and Protection
                [6 ]Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions
                [7 ]Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection
                [8 ]Soochow University
                [9 ]Suzhou 215123
                Article
                10.1039/C7NR06373C
                29135009
                53307647-ec96-431f-a744-71bf217ca98b
                © 2018

                http://rsc.li/journals-terms-of-use

                History

                Comments

                Comment on this article